Recombinant antigens
Tpp47
for Treponema pallidum
Tpp47 is one of the major antigenic components of the bacterium Treponema pallidum. It triggers an early humoral response three to six days after infection. The Tpp47 antigen has been reported as a potential market for active syphilis disease, as anti-Tpp47 IgM have been detected in patients with congenital syphilis.
- NAME
- Tpp47
- DESCRIPTION
- Membrane lipoprotein
- GEN
- Tpp47
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format- Monobiotinylated
Esta proteína está diponible monobiotinilada
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen Tpp47
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Monobiotinylated proteins
- IVD reagents for TORCH
- Sexually transmitted diseases (STD)
- IVD reagents for Transfusion-Transmitted Infectious diseases
- Recombinant antigens for diagnosis of Syphilis
Videos
Evaluaciones
Related proteins
Reagent sheet
- NAME
- Tpp47
- DESCRIPTION
- Membrane lipoprotein
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format- Monobiotinylated
Esta proteína está diponible monobiotinilada
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
